KCM
PRAH

Kornitzer Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Kornitzer Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-166,386
Closed -$13.8M – 534
2020
Q1 		$13.8M Sell
166,386
-65,042
-28% -$6.34M 0.33% 113
2019
Q4 		$25.7M Buy
231,428
+16,608
+8% +$1.71M 0.45% 72
2019
Q3 		$21.3M Buy
+214,820
New +$21.3M 0.39% 88

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Kornitzer Capital Management's PRAH Position: Q2 2020 in Review

Kornitzer Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 166,386 shares — an estimated $13.8M sold.

Kornitzer Capital Management first reported a position in PRAH in Q3 2019 and held it in 3 quarters. The position peaked at $25.7M in Q4 2019. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Kornitzer Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Kornitzer Capital Management sold 166,386 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $13.8M.
  • Kornitzer Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 3 quarters.
  • Kornitzer Capital Management's PRA Health Sciences, Inc. position peaked at $25.7M in Q4 2019.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Kornitzer Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.